|
The CCNY/MSKCC Partnership for Research, Training and Outreach
|
3U54CA137788-02S1
|
$200,000
|
$24,000
|
Ahles, Tim
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
The CCNY/MSKCC Partnership for Research, Training and Outreach
|
5U54CA137788-02
|
$1,404,429
|
$168,531
|
Ahles, Tim
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Treatment of Osteoradionecrosis with Bone Marrow Stromal Cells
|
5K08CA120875-04
|
$138,333
|
$138,333
|
AKINTOYE, SUNDAY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Antigen Specific T Cell tolerance by Anti CD3 Antibodies
|
5R01CA132197-07
|
$374,107
|
$374,107
|
ANASETTI, CLAUDIO
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Molecular Studies of Cellular Cytotoxicity
|
ZIA BC 010013
|
$539,872
|
$107,974
|
Anderson, Stephen
|
CCR (NCI)
|
|
THE THERAPY OF AML
|
5P01CA055164-17
|
$2,440,745
|
$610,186
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Mechanisms of GVHD
|
9P01CA142106-06A1
|
$1,953,263
|
$1,953,263
|
ANTIN, JOSEPH
|
DANA-FARBER CANCER INSTITUTE
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$279,762
|
$27,976
|
Aplan, Peter
|
CCR (NCI)
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$279,762
|
$279,762
|
Aplan, Peter
|
CCR (NCI)
|
|
Adult Leukemia Research Center
|
5P01CA018029-34
|
$5,273,382
|
$4,429,641
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-25
|
$638,492
|
$638,492
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL)
|
ZIA SC 010282
|
$144,797
|
$14,480
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$506,790
|
$253,395
|
Arthur, Diane
|
CCR (NCI)
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
ZIA BC 010997
|
$217,176
|
$217,176
|
Avital, Itzhak
|
CCR (NCI)
|
|
Asymmetric Division and Self Renewal of Cancer Stem Cells
|
ZIA BC 011003
|
$542,939
|
$108,588
|
Avital, Itzhak
|
CCR (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIA BC 011004
|
$108,588
|
$108,588
|
Avital, Itzhak
|
CCR (NCI)
|
|
Isolation and Purification of Cancer Stem Cells Based on Functional Appraoch
|
ZIA BC 011005
|
$217,176
|
$217,176
|
Avital, Itzhak
|
CCR (NCI)
|
|
Southwest Oncology Group
|
5U10CA027057-30
|
$267,015
|
$2,670
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-30
|
$9,379,270
|
$93,793
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
7R01CA112530-04
|
$501,100
|
$501,100
|
BAKER, KEVIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Growth Control in Multiple Myeloma
|
2P01CA055819-15
|
$3,715,800
|
$1,857,900
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
Growth Control in Multiple Myeloma
|
3P01CA055819-14S1
|
$849,984
|
$424,992
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
Surgical Oncology Research Training
|
5T32CA106493-05
|
$108,412
|
$27,103
|
BEHRNS, KEVIN
|
UNIVERSITY OF FLORIDA
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$3,736
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$3,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$4,301
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$350,667
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Career Development in Pediatric and Medical Oncology
|
2K12CA076930-11
|
$595,080
|
$297,540
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-31
|
$223,195
|
$89,278
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT
|
ZIA BC 010698
|
$167,837
|
$117,486
|
Bishop, Michael
|
CCR (NCI)
|
|
Relapse after Allogeneci Hematopoietic Stem Cell Transplantation
|
ZIA BC 011239
|
$167,837
|
$167,837
|
Bishop, Michael
|
CCR (NCI)
|
|
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT
|
ZIA SC 010365
|
$223,783
|
$22,378
|
Bishop, Michael
|
CCR (NCI)
|
|
Cytotoxic-T-Lymphocyte (CTL) Therapy of AML
|
5R01CA072669-13
|
$298,185
|
$298,185
|
Blazar, Bruce
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Identification of Hematopoietic Stem and Progenitor Cell Viability Genes
|
1R43CA141848-01
|
$249,465
|
$249,465
|
Bonneau, Kyle
|
CELLECTA, INC.
|
|
The role of myeloid suppressor cells in tumor-specific tolerance
|
5R01CA124996-03
|
$336,036
|
$110,892
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Marrow Infiltrating Lymphocyte Immunotherapy in Myeloma
|
5R21CA130344-02
|
$369,000
|
$369,000
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Reconstitution of T cell immunity after UCB transplantation: The role of Treg
|
5R21CA123855-02
|
$390,741
|
$390,741
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Hematopoietic Lineage-restricted Minor Histocompatibility Antigens as GVL Targets
|
5R01CA118880-03
|
$235,181
|
$235,181
|
BRICKNER, ANTHONY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Southwest Oncology Group
|
5U10CA004919-50
|
$195,727
|
$1,957
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Cancer Center Support Grant
|
3P30CA046934-22S1
|
$146,023
|
$4,381
|
Byers, Tim
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
3P30CA046934-22S2
|
$85,992
|
$2,580
|
Byers, Tim
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
5P30CA046934-22
|
$4,497,135
|
$134,914
|
Byers, Tim
|
UNIVERSITY OF COLORADO DENVER
|
|
Novel Approaches to Stem Cell Transplantation
|
2P01CA047741-16A1
|
$1,827,050
|
$1,224,124
|
CHAO, NELSON
|
DUKE UNIVERSITY
|
|
Significance of mutations in human NOTCH1 in T cell acute lymphoblastic leukemia
|
5K08CA120544-04
|
$133,272
|
$33,318
|
CHIANG, MARK
|
UNIVERSITY OF PENNSYLVANIA
|
|
Mechanisms of Symptoms of Multiple Myeloma and Its Therapy
|
5P01CA124787-02
|
$2,146,525
|
$214,653
|
CLEELAND, CHARLES
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Enhancing the efficacy of CD19-specific cord blood-derived T Cells
|
5R01CA120956-03
|
$292,600
|
$146,300
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adoptive immunotherapy after umbilical cord blood transplant
|
5R01CA124782-03
|
$292,600
|
$292,600
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Southwest Oncology Group Statistical Center
|
5U10CA038926-24
|
$4,746,162
|
$47,462
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
In vivo targeted DC vaccine to activate anti-tumor CTL
|
5R01CA112065-05
|
$338,640
|
$338,640
|
CUI, YAN
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-02
|
$1,463,613
|
$58,545
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
Total relevant funding to Organ Transplantation Research for this search: $77,809,088
|